(Sharecast News) - SkinBioTherapeutics announced on Thursday that final testing of its 'SkinBiotix' technology by Croda Beauty Care had yielded positive results, paving the way for commercialisation.
The AIM-traded company said the testing, conducted in collaboration with Croda's Sederma team, validated the efficacy and marketing claims of SkinBiotix, bolstering its potential...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE